<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00767923</url>
  </required_header>
  <id_info>
    <org_study_id>2008-011</org_study_id>
    <nct_id>NCT00767923</nct_id>
  </id_info>
  <brief_title>Validation of OxyVu for Assessing Level of Amputation With Comparison to Other Modalities</brief_title>
  <acronym>LOA</acronym>
  <official_title>Clinical Validation of HyperMed OxyVu Tissue Oximeter for Assessing Level of Amputation With Comparison to Other Modalities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HyperMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Carl T. Hayden VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>HyperMed</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Correlation of(OxyVu) values to to ABI, TBP, and TCOM in patients scheduled for foot level
      amputation because of critical limb ischemia, infection, or tissue necrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this clinical study is to correlate tissue oxygenation values measured with a
      hyperspectral imaging system (OxyVu) to Ankle Brachial Indices (ABI), toe pressures (TBP),
      and transcutaneous oxygen monitoring (TCOM) in patients scheduled for foot level amputation
      because of critical limb ischemia, infection, or tissue necrosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assess predictive value for healing by 8 weeks of OxyVu, ABI, TBI and TCOM measured prior to amputation. OxyVu readings for oxyhemoglobin, deoxyhemoglobin and oxygen saturation will be compared to healing potential predicted from ABI, TBI, and TCOM.</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Collect additional interventions required through review of patient medical records at 12 months</measure>
    <time_frame>12 Months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Critical Limb Ischemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        18 to 85 years of age, males and females, varying skin tones, varying racial origins, and
        with and without diabetes.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 85 years of age, males and females, varying skin tones, varying racial origins,
             and with and without diabetes.

          -  Patients scheduled for foot level amputation because of critical limb ischemia,
             infection, or tissue necrosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert G Frykberg, DPM MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carl T. Hayden VA Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Carl T Hayden VA Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.hypermed-inc.com</url>
    <description>Sponsor and OxyVu technology website</description>
  </link>
  <reference>
    <citation>Second European Consensus Document on chronic critical leg ischemia. Eur J Vasc Surg. 1992 May;6 Suppl A:1-32. Review.</citation>
    <PMID>1533191</PMID>
  </reference>
  <reference>
    <citation>Deerochanawong C, Home PD, Alberti KG. A survey of lower limb amputation in diabetic patients. Diabet Med. 1992 Dec;9(10):942-6.</citation>
    <PMID>1478041</PMID>
  </reference>
  <reference>
    <citation>Frykberg RG. Guidelines for diabetic foot care. Foot Ankle Int. 2000 Jul;21(7):616.</citation>
    <PMID>10919631</PMID>
  </reference>
  <reference>
    <citation>Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagner EH. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999 Mar;22(3):382-7.</citation>
    <PMID>10097914</PMID>
  </reference>
  <reference>
    <citation>Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care. 2000 Sep;23(9):1333-8.</citation>
    <PMID>10977028</PMID>
  </reference>
  <reference>
    <citation>Greenman RL, Panasyuk S, Wang X, Lyons TE, Dinh T, Longoria L, Giurini JM, Freeman J, Khaodhiar L, Veves A. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet. 2005 Nov 12;366(9498):1711-7.</citation>
    <PMID>16291064</PMID>
  </reference>
  <reference>
    <citation>Zuzak KJ, Schaeberle MD, Gladwin MT, Cannon RO 3rd, Levin IW. Noninvasive determination of spatially resolved and time-resolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique. Circulation. 2001 Dec 11;104(24):2905-10.</citation>
    <PMID>11739304</PMID>
  </reference>
  <reference>
    <citation>Khaodhiar L, Dinh T, Schomacker KT, Panasyuk SV, Freeman JE, Lew R, Vo T, Panasyuk AA, Lima C, Giurini JM, Lyons TE, Veves A. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Diabetes Care. 2007 Apr;30(4):903-10. Epub 2007 Feb 15.</citation>
    <PMID>17303790</PMID>
  </reference>
  <reference>
    <citation>Benaron DA, Parachikov IH, Friedland S, Soetikno R, Brock-Utne J, van der Starre PJ, Nezhat C, Terris MK, Maxim PG, Carson JJ, Razavi MK, Gladstone HB, Fincher EF, Hsu CP, Clark FL, Cheong WF, Duckworth JL, Stevenson DK. Continuous, noninvasive, and localized microvascular tissue oximetry using visible light spectroscopy. Anesthesiology. 2004 Jun;100(6):1469-75.</citation>
    <PMID>15166566</PMID>
  </reference>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2008</study_first_submitted>
  <study_first_submitted_qc>October 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2008</study_first_posted>
  <last_update_submitted>June 2, 2009</last_update_submitted>
  <last_update_submitted_qc>June 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kevin Schomacker, PhD</name_title>
    <organization>HyperMed, Inc.</organization>
  </responsible_party>
  <keyword>hyperspectral imaging</keyword>
  <keyword>tissue oxygenation</keyword>
  <keyword>foot amputation</keyword>
  <keyword>critical limb ischemia</keyword>
  <keyword>tissue necrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

